Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000935836-25-000476
Filing Date
2025-07-30
Accepted
2025-07-30 18:20:32
Documents
1
Period of Report
2025-07-28

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 10174
  Complete submission text file 0000935836-25-000476.txt   11988
Mailing Address 357 TEHAMA STREET #3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET #3 SAN FRANCISCO CA 94103 415-448-6534
EcoR1 Capital, LLC (Reporting) CIK: 0001587114 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37368 | Film No.: 251168504

Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE United Kingdom
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE United Kingdom 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)